Cost Effectiveness of Recombinant Zoster Vaccine and Live-Attenuated Vaccine Against Herpes Zoster for Adults Aged 50 and Over in China
The strategy utilizing RZV demonstrated superior efficacy in reducing the burden of HZ compared with ZVL. RZV was most cost effective in the 50-59, 60-69 and ≥ 80 years age groups, and ZVL was most cost effective in the 70-79 years group.
Authors
- Mingming Chu
- Yamin Shu (ORCID: https://orcid.org/0000-0002-1532-8135)
- Lulu Liu (ORCID: https://orcid.org/0000-0001-9257-9512)
- Zhe Zhang (ORCID: https://orcid.org/0000-0002-2725-4014)
- Rong Zhang (ORCID: https://orcid.org/0000-0001-5824-5447)
- Qilin Zhang (ORCID: https://orcid.org/0000-0002-4779-3875)
- Lei Wang (ORCID: https://orcid.org/0000-0003-1454-9283)
- Zongwen Shuai (ORCID: https://orcid.org/0000-0002-4657-1103)
Institutions
- Union Hospital (HK)
- Army Medical University (CN)
- Xinqiao Hospital (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1007/s41669-025-00604-z
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Army Medical University